Showing results (81-90 of 138) with videos related to
Sort By:
Pageof 14
European Journal of Immunology|January 1, 1989
Isolation of rat IgM to IgG hybridoma isotype switch variants and analysis of the efficiency of rat Ig in complement activationG Pluschke, G Bordmann, M E Daoudaki, et al.Developmental and Comparative Immunology|September 12, 2000
Cloning and structure of three rainbow trout C3 molecules: a plausible explanation for their functional diversityI K Zarkadis, M R Sarrias, G Sfyroera, et al.Immunology|July 1, 1985
Regulation of immunoglobulin secretion by factor H of human complementG C Tsokos, G Inghirami, C D Tsoukas, et al.Proceedings of the National Academy of Sciences of the United States of America|January 20, 1999
Role of decay-accelerating factor in regulating complement activation on the erythrocyte surface as revealed by gene targetingX Sun, C D Funk, C Deng, et al.The Journal of Biological Chemistry|July 25, 1990
Resonance Raman studies of iron spin and axial coordination in distal pocket mutants of ferric myoglobinD Morikis, P M Champion, B A Springer, et al.Journal of Immunology (Baltimore, Md. : 1950)|March 1, 1990
Monovalent ligands of complement receptor 2 inhibit whereas polyvalent ligands enhance anti-Ig-induced human B cell intracytoplasmic free calcium concentrationG C Tsokos, J D Lambris, F D Finkelman, et al.European Journal of Immunology|May 1, 1992
Interaction between Epstein-Barr virus and a T cell line (HSB-2) via a receptor phenotypically distinct from complement receptor type 2J A Hedrick, D Watry, C Speiser, et al.Advances in Experimental Medicine and Biology|September 28, 2011
Differential effect of inhibiting MD-2 and CD14 on LPS- versus whole E. coli bacteria-induced cytokine responses in human bloodD Christiansen, O L Brekke, J Stenvik, et al.Journal of Immunology (Baltimore, Md. : 1950)|August 1, 1996
Complement activation by a B cell superantigenL M Kozlowski, A M Soulika, G J Silverman, et al.Immunology|April 1, 1985
Antigenic relationship between the alpha-chain of C3, a leucocyte-surface antigen involved in the activation of phagocytic cells, and a 50,000 MW B-cell antigenT F Schulz, H Scharfenberger, J D Lambris, et al.Pageof 14